IDT Australia
End-to-end cGMP CDMO solutions from API to finished dosage forms.
IDT Australia is a cGMP CDMO delivering end-to-end pharmaceutical development and manufacturing services from active pharmaceutical ingredients to finished dosage forms, with expertise in small molecule APIs, specialty orals, advanced therapies, and integrated regulatory support. Headquartered in Australia.
Modalities
Development & manufacturing
Structured CDMO capabilities from verified public sources.
Manufacturing (M)
Synthetic chemistry infrastructure
- Capabilities
- HPAPIDEA licensed
Fill-finish formats
Services
- HPAPI Manufacturing (High-Potency)
- Process Development
- Secondary Packaging & Labeling
- API Synthesis & Manufacturing
- Small Molecule Development & Manufacturing
- ADC Payload & Linker Synthesis
- ADC (Antibody-Drug Conjugate) Manufacturing
- Formulation Development
- Oral Solid Dosage Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Vial Filling
- Lyophilization (Freeze Drying)
- CMC Analytical Development
- Stability Testing & Storage
- Quality Control Testing
- Regulatory Affairs
- CMC Regulatory Submission Support
- Technology Transfer
Indications
About this organization
Overview
IDT Australia (ASX: IDT) is a contract development and manufacturing organization (CDMO) providing end-to-end cGMP solutions for pharmaceutical partners worldwide. The company advances medicines from concept through commercialization, offering integrated R&D, formulation, and manufacturing expertise.
Core Service Lines
Active Pharmaceutical Ingredients (APIs)
- Small molecule API expertise
- Highly potent and cytotoxic compounds
- Pre-clinical to commercial scale manufacturing
- Linker-payload manufacture for antibody-drug conjugates (ADCs)
Specialty Orals
- Formulation and production of solid oral dosage forms
- Tablets and capsules
- Non-sterile liquid products
- Schedule 8 and 9 drug products
Advanced Therapies
- Advanced sterile fill and finish into vials
- Lyophilization services
- Radiopharmaceutical manufacturing
Integrated Services
- Research & Development
- Analytical and microbiological testing
- ICH stability testing
- Labeling and packaging
- Project management
- Supply chain and distribution
- Regulatory support
Differentiation
IDT Australia emphasizes globally recognized quality standards meeting international benchmarks, bespoke and agile manufacturing tailored to unique project requirements, and a highly skilled workforce combining advanced technical expertise with industry experience. The company highlights Australia's advantages as a pharmaceutical manufacturing hub, including cost efficiency, rapid study start-up, streamlined regulatory pathways, and R&D tax incentives.
Locations
Headquarters
Australia
Related companies
Similar profiles by shared services, modalities, and capabilities.
Carbogen Amcis- HPAPI Manufacturing (High-Potency)
- Process Development
Ardena- HPAPI Manufacturing (High-Potency)
- Process Development
- BSP Pharmaceuticals
- HPAPI Manufacturing (High-Potency)
- Process Development
Quotient Sciences- HPAPI Manufacturing (High-Potency)
- Process Development
Sai Life Sciences- Process Development
- API Synthesis & Manufacturing
Axplora- HPAPI Manufacturing (High-Potency)
- Process Development
Pharmaceutics International, Inc.- HPAPI Manufacturing (High-Potency)
- Process Development
Pfizer CentreOne- Process Development
- ADC (Antibody-Drug Conjugate) Manufacturing
Submit a verified review for this organization.
Markdown mirror: /companies/idtaus-com.md